A 5-HT1A receptor mixed antagonist and partial agonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

NAN-190

Item No. 29314

Technical Information
Formal Name
2-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]-1H-isoindole-1,3(2H)-dione, monohydrobromide
CAS Number
115338-32-4
Molecular Formula
C23H27N3O3 • HBr
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 5 mg/mlDMSO: 10 mg/mlDMSO:PBS (pH 7.2) (1:1): 0.5 mg/mlEthanol: 1 mg/ml
λmax
214, 219, 233, 241 nm
SMILES
O=C1N(CCCCN2CCN(C3=CC=CC=C3OC)CC2)C(C4=CC=CC=C41)=O.Br
InChi Code
InChI=1S/C23H27N3O3.BrH/c1-29-21-11-5-4-10-20(21)25-16-14-24(15-17-25)12-6-7-13-26-22(27)18-8-2-3-9-19(18)23(26)28;/h2-5,8-11H,6-7,12-17H2,1H3;1H
InChi Key
AXRUEPFPTQYHQD-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    NAN-190 is a mixed antagonist and partial agonist of the serotonin (5-HT) receptor subtype 5-HT1A.1 It inhibits radioligand binding to 5-HT1A sites in rat hippocampal membranes (Ki = 2 nM). NAN-190 decreases 5-carboxamidotryptamine-mediated inhibition of forskolin-induced adenylyl cyclase activity in guinea pig hippocampal membranes in a concentration-dependent manner, indicating partial agonist activity. NAN-190 also antagonizes α1-adrenergic receptors (α1-ARs; pA2s = 9.47, 9.02, and 9.99 in isolated rat tail artery, rabbit aorta, and rat aorta, respectively).2 In vivo, NAN-190 (1-300 μg/kg) decreases blood pressure, without modifying heart rate, in anesthetized rats. It inhibits phenylephrine-induced pressor responses in pithed rats. NAN-190 (5 mg/kg, i.p.) potentiates the circadian response to light in dark-adapted and entrained hamsters.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Rydelek-Fitzgerald, L., Teitler, M., Fletcher, P.W., et alNAN-190: Agonist and antagonist interactions with brain 5-HT1A receptors. Brain Res. 532(1-2), 191-196 (1990).

    2. Villalobos-Molina, R., Gallardo-Ortíz, I.A., López-Guerrero, J.J., et alEvidence that NAN-190-induced hypotension involves vascular α1-adrenoceptor antagonism in the rat. Eur. J. Pharmacol. 455(1), 59-64 (2002).

    3. Kessler, E.J., Sprouse, J., and Harrington, M.E. NAN-190 potentiates the circadian response to light and speeds re-entrainment to advanced light cycles. Neuroscience 154(4), 1187-1194 (2008).